Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
3.255
-0.105 (-3.12%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Regentis Biomaterials Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 17 | 35 | - | - | - | - | |
| Enterprise Value | 11 | 78 | - | - | - | - | |
| Last Close Price | 3.36 | 6.74 | - | - | - | - | |
| PB Ratio | 3.67 | 7.36 | - | - | - | - | |
| P/TBV Ratio | 3.67 | 7.36 | - | - | - | - | |
| Debt / Equity Ratio | 0.25 | 0.25 | -0.82 | -0.70 | -0.80 | -0.94 | |
| Net Debt / Equity Ratio | -1.30 | -1.30 | -0.78 | -0.67 | -0.65 | -0.51 | |
| Quick Ratio | 2.65 | 2.65 | 0.05 | 0.11 | 0.14 | 1.02 | |
| Current Ratio | 2.65 | 2.65 | 0.07 | 0.12 | 0.19 | 1.14 | |
| Return on Assets (ROA) | -107.53% | -107.53% | 138.36% | -116.21% | -36.40% | -18.55% | |
| Return on Capital Employed (ROCE) | -146.90% | -146.90% | -15.50% | 69.50% | 19.10% | -170.40% | |
| Earnings Yield | -78.68% | -39.10% | - | - | - | - | |
| Buyback Yield / Dilution | -249.41% | -249.41% | 6.52% | -6.97% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.